Tender Details

Country: Germany
Summary: Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Interferon Beta-1A (Rebif) from the 87.Vv
DET Ref No: 131208302
Deadline: 11 Dec 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: Refer Document
Notice Type: Tender
Document Ref. No.: 794971-2025
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
Section 130a Paragraph 8 SGB V enables health insurance companies (KK) and pharmaceutical companies to conclude framework discount agreements for the medicines to be supplied at the expense of the statutory KK. The GWQ is a society for efficiency and quality at KK in accordance with Section 130a Paragraph 8 Sentence 5 SGBV for its Shareholder and customer funds. With regard to the relevant legal regulations for the awarding of public contracts, a regular process of active ingredient-related, formal award procedures takes place in accordance with the regulations of Part 4 of the GWB by GWQ ServicePlus AG. Start of contract is January 1st, 2026.
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Interferon beta-1a (Rebif) -VV 87
The GWQ ServicePlus AG intends to enter into non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V in relation to the above. Active ingredient with contract start on January 1st, 2026 to close. All interested companies can join this contract at any time during the contract term under the same conditions (approval model). The GWQ assumes that this procedure is due to a lack of a selection decision and therefore the possibility of non-discriminatory access of all pharmaceutical companies does not fall within the scope of antitrust procurement law. The contract documents, the participating health insurance companies and their sales as well as the dates for reporting the contract are available on the GWQ ServicePlus AG procurement portal http://verga...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Interferon Beta-1A (Rebif) from the 87.Vv - Germany Tender

The GWQ SERVICEPLUS AG, a Government sector organization in Germany, has announced a new tender for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for Interferon Beta-1A (Rebif) from the 87.Vv. This tender is published on GermanyTenders under DET Ref No: 131208302 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-11.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.